Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19

被引：7
|
作者：
Landmesser, Ulf [1 ,2 ,3 ]
Lehmann, Irina [2 ,4 ,5 ,6 ]
Eils, Roland [2 ,4 ,5 ,7 ]
机构：
[1] Charite Univ Med Berlin, Dept Cardiol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany
[2] Berlin Inst Hlth, Berlin, Germany
[3] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany
[4] Charite Univ Med Berlin, Kapelle Ufer 2, D-12555 Berlin, Germany
[5] Free Univ Berlin, Kapelle Ufer 2, D-12555 Berlin, Germany
[6] Humboldt Univ, Mol Epidemiol Unit, Kapelle Ufer 2, D-12555 Berlin, Germany
[7] Humboldt Univ, Digital Hlth Ctr, Kapelle Ufer 2, D-12555 Berlin, Germany
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷 / 18期
关键词：
D O I：
10.1093/eurheartj/ehab191
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1720 / 1721
页数：2
相关论文
共 50 条
  • [21] Impact of Underlying Cardiovascular Disease for the Hospitalized Covid-19 Patients in Delaware
    Zhang, Zugui
    Chiam, Tze Chao
    Gbadebo, Bayo
    Jurkovitz, Claudine
    Mount-Campbell, Austin
    Harrison, Cecelia
    Bollinger, Melissa
    Hicks, Leroi
    Papas, Mia
    CIRCULATION, 2020, 142
  • [22] THROMBOEMBOLIC OUTCOMES IN HOSPITALIZED PATIENTS WITH UNDERLYING CARDIOVASCULAR DISEASE AND COVID-19
    Khairani, Candrika
    Barns, Briana M.
    Pfeferman, Mariana
    Snyder, Julia E.
    Goldhaber, Samuel
    Piazza, Gregory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3139 - 3139
  • [23] Clinical Features of Admitted Patients with COVID-19 and Underlying Rheumatic Diseases
    Heo, Jeonghun
    Her, Minyoung
    BAHRAIN MEDICAL BULLETIN, 2023, 45 (03) : 1714 - 1718
  • [24] Effects of Covid-19 on Patients with Cardiovascular Diseases: A Systematic Review
    Sharma, Naveen
    Joshi, Priyanka
    Gupta, Pawan Kumar
    Shukla, Parjanya Kumar
    Archna
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (53B) : 130 - 135
  • [25] Ruxolitinib in COVID-19 patients with defined hyperinflammation: the RuxCoFlam trial
    Birndt, S.
    Hammersen, J.
    Doehner, K.
    Reuken, P.
    Sauerbrey, P.
    La Rosee, F.
    Pfirrmann, M.
    Fabisch, C.
    Weiss, M.
    Traeger, K.
    Bremer, H.
    Illerhaus, G.
    Droemann, D.
    Schneider, S.
    La Rosee, P.
    Hochhaus, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 71 - 71
  • [26] Ruxolitinib in COVID-19 patients with defined hyperinflammation: The RuxCoFlam trial
    Hammersen, J.
    Birndt, S.
    Doehner, K.
    Fabisch, C.
    Weiss, M.
    Bremer, H.
    Illerhaus, G.
    Droemann, D.
    La Rosee, P.
    Hochhaus, A.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2023, 118 (05)
  • [27] Editorial: Dysregulation of immunity predisposing to severe COVID-19 infection
    Halwani, Rabih
    Pulvirenti, Federica
    Al-Muhsen, Saleh
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Is There a Role for Environmental and Metabolic Factors Predisposing to Severe COVID-19?
    Bornstein, Stefan R.
    Voit-Bak, Karin
    Schmidt, Dieter
    Morawietz, Henning
    Bornstein, Alexander Benjamin
    Balanzew, Waldimir
    Julius, Ulrich
    Rodionov, Roman N.
    Biener, Anne Maria
    Wang, Jun
    Schulte, Klaus-Martin
    Krebs, Peter
    Vollmer, Guenter
    Straube, R.
    HORMONE AND METABOLIC RESEARCH, 2020, 52 (07) : 540 - 546
  • [29] Severe forms of COVID-19 among patients with chronic respiratory diseases: be attentive to the severity of the underlying respiratory impairment
    Valentin, S.
    Basin, S.
    Chaouat, A.
    RESPIRATORY MEDICINE AND RESEARCH, 2022, 81
  • [30] HYPERINFLAMMATION AND CLINICAL OUTCOMES FOR PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES HOSPITALIZED FOR COVID-19: A COMPARATIVE COHORT STUDY
    Hsu, T.
    D'silva, K.
    Serling-Boyd, N.
    Wang, J.
    Mueller, A.
    Fu, X.
    Prisco, L.
    Martin, L.
    Vanni, K.
    Zaccardelli, A.
    Cook, C.
    Choi, H.
    Zhang, Y.
    Gravallese, E.
    Wallace, Z.
    Sparks, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 867 - 868
12345